These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9424759

  • 21. [The results of the repeat treatment of primary resistant hematosarcomas].
    Kruglova GV, Aliev DA, Samedov IV.
    Vopr Onkol; 1991; 37(3):345-50. PubMed ID: 2031331
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
    Doubek M, Mayer J, Korístek Z, Protivánková M, Brychtová Y, Oborilová A, Král Z, Klabusay M, Tomíska M, Buchtová I, Vorlícek J.
    Cas Lek Cesk; 2002 Mar 01; 141(4):122-6. PubMed ID: 12046256
    [Abstract] [Full Text] [Related]

  • 23. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH.
    Cancer; 2005 Jan 15; 103(2):368-76. PubMed ID: 15599932
    [Abstract] [Full Text] [Related]

  • 24. [Childhood leukemia from the perspective of 15 years of its intensive treatment].
    Radwańska U.
    Pediatr Pol; 1988 Nov 15; 63(11):689-92. PubMed ID: 3253654
    [No Abstract] [Full Text] [Related]

  • 25. Which factors influence the different outcome of therapy in adults and children with ALL?
    Hoelzer D.
    Bone Marrow Transplant; 1989 Jan 15; 4 Suppl 1():98-100. PubMed ID: 2653528
    [No Abstract] [Full Text] [Related]

  • 26. Cryptococcal meningitis in a child with acute lymphoblastic leukemia.
    Mavinkurve-Groothuis AM, Bokkerink JP, Verweij PE, Veerman AJ, Hoogerbrugge PM.
    Pediatr Infect Dis J; 2003 Jun 15; 22(6):576. PubMed ID: 12799518
    [No Abstract] [Full Text] [Related]

  • 27. Immunosuppression in childhood acute lymphoblastic leukemia after remission induction therapy concerns B not T lymphocytes.
    Luczynski W, Krawczuk-Rybak M, Muszynska-Roslan K, Stasiak-Barmuta A, Zak J.
    Med Pediatr Oncol; 2002 Aug 15; 39(2):147-8. PubMed ID: 12116070
    [No Abstract] [Full Text] [Related]

  • 28. [Infections during the induction treatment of acute lymphoid leukemia (ALL). The importance of preventive measures].
    Rodriguez Pedroso EC, Cuni Torriente L, González Otero A, Svarch E, Delgado C.
    Rev Cubana Enferm; 1988 Aug 15; 4(1-2):120-30. PubMed ID: 3238112
    [No Abstract] [Full Text] [Related]

  • 29. Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission.
    Oh H, Gale RP, Zhang MJ, Passweg JR, Ino T, Murakami H, Ohno R, Rowlings PA, Sobocinski KA, Tanimoto M, Tomonaga M, Weisdorf DJ, Horowitz MM.
    Bone Marrow Transplant; 1998 Aug 15; 22(3):253-7. PubMed ID: 9720738
    [Abstract] [Full Text] [Related]

  • 30. [Recent progress in the treatment of hematological malignancies. II. Acute lymphoblastic leukemia (ALL)].
    Shirakawa S, Kita K, Kobayashi T.
    Nihon Naika Gakkai Zasshi; 1989 Jun 15; 78(6):769-73. PubMed ID: 2794658
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment of adult acute lymphoblastic leukemia by KHALL-93--long-term outcome].
    Usuki K, Adachi Y, Kazama K, Iki S, Urabe A.
    Gan To Kagaku Ryoho; 2000 Aug 15; 27(9):1397-402. PubMed ID: 10969595
    [Abstract] [Full Text] [Related]

  • 32. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Haematologica; 2008 Jun 15; 93(6):834-41. PubMed ID: 18469352
    [Abstract] [Full Text] [Related]

  • 33. [Therapeutic results of acute lymphoblastic leukemia in children in Tunisia (181 cases)].
    Meddeb B, Ben Abdallah M, Hafsia R, Ben Othman T, Hafsia A, Mtimet S, Boussen M.
    Tunis Med; 1987 Mar 15; 65(3):183-7. PubMed ID: 3504645
    [No Abstract] [Full Text] [Related]

  • 34. Cancer and Leukemia Group B (CALGB) studies in adult acute lymhocytic leukemia.
    Schiffer CA, Larson RA, Bloomfield CD.
    Leukemia; 1992 Mar 15; 6 Suppl 2():171-4. PubMed ID: 1578925
    [No Abstract] [Full Text] [Related]

  • 35. [Recent progress in the treatment of acute leukemia].
    Kimura Y.
    Gan To Kagaku Ryoho; 2003 Jul 15; 30(7):895-901. PubMed ID: 12894700
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
    Ho CL, Chen YC, Kao WY, Chao TY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan 15; 63(1):45-52. PubMed ID: 10645050
    [Abstract] [Full Text] [Related]

  • 38. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C, Auclerc MF, Levy V, Porcher R, Piguet C, Perel Y, Gandemer V, Debre M, Vermylen C, Pautard B, Berger C, Schmitt C, Leblanc T, Cayuela JM, Socie G, Michel G, Leverger G, Baruchel A.
    J Clin Oncol; 2008 Mar 20; 26(9):1496-503. PubMed ID: 18349402
    [Abstract] [Full Text] [Related]

  • 39. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O, Pigneux A, Huguet F, Vey N, Delannoy A, Fegueux N, de Botton S, Stamatoullas A, Tournilhac O, Buzyn A, Charrin C, Boucheix C, Gabert J, Lhéritier V, Vernant JP, Fière D, Dombret H, Thomas X, GET-LALA group.
    Leuk Res; 2008 Nov 20; 32(11):1741-50. PubMed ID: 18508120
    [Abstract] [Full Text] [Related]

  • 40. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
    Hunault M, Truchan-Graczyk M, Caillot D, Harousseau JL, Bologna S, Himberlin C, Guyotat D, Berthou C, Casassus P, Baranger L, Béné MC, Ifrah N, Gyan E, GOELAMS Group.
    Haematologica; 2007 Dec 20; 92(12):1623-30. PubMed ID: 18055985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.